RUBIN PAUL D bought BIOA
April 1, 2026 · Form 4 insider transaction
RUBIN PAUL D bought 5,437 shares of BioAge Labs, Inc. at $4.11 per share, a transaction worth $22.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,437
Price
$4.11
Total value
$22.3K
InsiderRUBIN PAUL D
RoleOfficer
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after5,437
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.